Endocan Corp
Thermic Sciences International develops and sells hemp based products. The company offers hemp formulation-based health and wellness solutions, as well as cosmeceuticals, nutraceuticals, and food brands. It also provides over the counter products for hair and skin include Hempery miracle oil, a skin care solution; Hemp milk body wash, a creamy soap; Hemp lotion bars for moisturizing hands and bod… Read more
Endocan Corp (ENDO) - Total Liabilities
Latest total liabilities as of March 2013: $1.49 Million USD
Based on the latest financial reports, Endocan Corp (ENDO) has total liabilities worth $1.49 Million USD as of March 2013.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Endocan Corp - Total Liabilities Trend (2000–2012)
This chart illustrates how Endocan Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Endocan Corp Competitors by Total Liabilities
The table below lists competitors of Endocan Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Tan Delta Systems PLC
LSE:TAND
|
UK | GBX227.60K |
|
Ellies
JSE:ELI
|
South Africa | ZAC294.11 Million |
|
CGS International Inc
PINK:CGSI
|
USA | $516.37K |
|
Baltic International USA Inc
PINK:BISA
|
USA | $5.09 Million |
|
ROMIOS GOLD RES
MU:D4R
|
Germany | €1.25 Million |
|
Vintage Wine Estates, Inc.
PINK:VWESQ
|
USA | $393.47 Million |
Liability Composition Analysis (2000–2012)
This chart breaks down Endocan Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 25319.97 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Endocan Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Endocan Corp (2000–2012)
The table below shows the annual total liabilities of Endocan Corp from 2000 to 2012.
| Year | Total Liabilities | Change |
|---|---|---|
| 2012-12-31 | $1.50 Million | +21.42% |
| 2011-12-31 | $1.24 Million | +4.82% |
| 2010-12-31 | $1.18 Million | +9.94% |
| 2009-12-31 | $1.07 Million | -34.84% |
| 2008-12-31 | $1.64 Million | +40.26% |
| 2007-12-31 | $1.17 Million | -13.70% |
| 2006-12-31 | $1.36 Million | +402.58% |
| 2005-12-31 | $270.41K | +539.39% |
| 2004-12-31 | $42.29K | +4467.17% |
| 2003-12-31 | $926.00 | -99.62% |
| 2002-12-31 | $244.87K | +1063.91% |
| 2001-12-31 | $21.04K | +34.19% |
| 2000-12-31 | $15.68K | -- |